FDA Classifies DNA Tests for Rare Inherited Repeat Disorders
Published Date: 5/29/2025
Rule
Summary
The FDA is officially putting a special DNA test for inherited nucleotide repeat disorders into a safer, middle-level category called Class II. This change means the test will have clear safety rules, making it easier and faster for patients to get access to these important medical tools. Labs and companies making these tests should get ready for the new rules, which aim to keep things safe without slowing down innovation.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Inherited DNA Test Reclassified to Class II
The FDA is classifying the inherited nucleotide repeat disorder DNA test into Class II (special controls). The Agency says this classification will provide a reasonable assurance of the device's safety and effectiveness.
Special Controls Will Be Codified
The FDA will identify and codify special controls that apply to the inherited nucleotide repeat disorder DNA test; those special controls will become part of the device's classification language. Labs and companies that make the test are implicated by the codified special controls.
Regulatory Burdens Reduced to Improve Access
The FDA states that classifying this test into Class II will reduce regulatory burdens and enhance patients' access to innovative, beneficial devices. The Agency says the action aims to keep devices safe without slowing down innovation.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in